TrialCancer biology & medicine2021

Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer.

Cuicui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.